Log in to save to my catalogue

The Importance of Neonatal Screening for Galactosemia

The Importance of Neonatal Screening for Galactosemia

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9823668

The Importance of Neonatal Screening for Galactosemia

About this item

Full title

The Importance of Neonatal Screening for Galactosemia

Publisher

Switzerland: MDPI AG

Journal title

Nutrients, 2022-12, Vol.15 (1), p.10

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Galactosemia is an inborn metabolic disorder caused by a deficient activity in one of the enzymes involved in the metabolism of galactose. The first description of galactosemia in newborns dates from 1908, ever since complex research has been performed on cell and animal models to gain more insights into the molecular and clinical bases of this cha...

Alternative Titles

Full title

The Importance of Neonatal Screening for Galactosemia

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9823668

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9823668

Other Identifiers

ISSN

2072-6643

E-ISSN

2072-6643

DOI

10.3390/nu15010010

How to access this item